Perrigo Company Awarded A Good Manufacturing Seal

Czurak, David
April 2002
Grand Rapids Business Journal;4/22/2002, Vol. 20 Issue 16, pB8
Reports on The National Sanitary Foundation (NSF) International's awarding of its first Good Manufacturing Practices (GMP) registration to pharmaceuticals, vitamins and nutritional supplements manufacturer Perrigo Co. Functions of NSF; Role of the NSF GMP in validating the standards of a facility; Identification of GMP as guidelines that assure a produced product has the identity and quality listed on the label. INSET: The Perrigo Company.


Related Articles

  • Product Recall, Flu Season Impact Perrigo Results. Emrich, Anne Bond // Grand Rapids Business Journal;2/7/2005, Vol. 23 Issue 6, p6 

    Discusses the financial performance of Perrigo Co. of Allegan, Michigan for the second quarter of fiscal 2005. Increase in net sales; Effect of the company's retail level recall of loratadine syrup on sales; Growth in the core vitamin product category of the company.

  • Perrigo rejects new Mylan bid. Investor's Business Daily // Investors Business Daily;4/30/2015, pA02 

    The article reports that drugstore supplier Perrigo Co. PLC has rejected the bid offered by American generic-drug maker Mylan NV following speculations that the bid would be bought by pharmaceutical company Teva Pharmaceutical Industries Ltd.

  • Pharma: Other News To Note.  // BioWorld Today;1/ 2/2013, Vol. 24 Issue 1, p4 

    The article reports on the merger agreement signed by Perrigo Co. of Allen, Michigan to acquire Chicago, Illinois-based Cobrek Pharmaceuticals Inc. for $45 million.

  • Mylan. Investor's Business Daily // Investors Business Daily;7/30/2015, pA02 

    The article reports on the announcement of pharmaceutical firm Mylan NV that it has received approval from regulations in Europe to push through with its proposal to aquire healthcare supplier Perrigo Co. PLC.

  • Generic Drugmakers Garner M&A Interest. Collins, Allison; Diakantonis, Demitri // Mergers & Acquisitions: The Dealermaker's Journal;Jan2016, Vol. 51 Issue 1, p8 

    The article reports on the active participation of dealmakers in the generic drug-making industry, which underscored by the merger and acquisition (M&A) activity from Perrigo Co. PLC, Cardinal Health Inc., Mylan NV, and Teva.

  • Drugmaker Drama Ends Without Hitch: Perrigo Shareholders Rebuff Mylan Bid. AMY REEVES // Investors Business Daily;11/13/2015, p00 

    The article reports that Perrigo Co. PLC's shareholders have opposed a hostile takeover bid by generic-drug manufacturer Mylan NV, resulting to the decline of Perrigo stock and an increase in Mylan stock. It reveals that Mylan stock posted a 12.9% increase while Perrigo stock has dropped by 6.2%...

  • First-time generic approvals.  // Formulary;May2006, Vol. 41 Issue 5, p213 

    The article features drugs from several pharmaceutical companies with generic approvals. Among the drugs are Teconazole vaginal suppositories 80 milligram from Perrigo Company, Teva Pharmaceutical Industries Ltd.'s Pravastatin tablets 10, 20, and 40 milligram, and Glipizide extended-release...

  • M&A Fever Grips Drugmakers. Investor's Business Daily // Investors Business Daily;5/4/2015, pA01 

    3 Merger activity is still heated in the specialty drug sector, with companies seeking buyouts of rivals, which often prefer to be a buyer instead. Top generic-drug maker

  • Hostile And Hopeful Teva Offers $40 Bil For Mylan. AMY REEVES // Investors Business Daily;4/22/2015, pA01 

    The article focuses on the $40 billion bid of Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. to acquire its competitor Mylan NV, which also shows interest to buy generic drug maker Perrigo Co. LLC. The stand of Mylan on Teva's acquisition bid is discussed. Also explained is...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics